ADIPOQ and metabolic dysfunction-associated steatotic liver disease: The results from previous studies suggested that low serum amylase levels were significantly associated with BMI, blood pressure, γ-glutamyltransferase levels, TG levels, fasting plasma glucose levels, serum adiponectin levels, non-alcoholic fatty liver disease and metabolic syndrome [22–24].